Pseudo-UTP
Catalog No.
B7972
A modified nucleoside-5’-O-triphosphate, commonly used for drugable mRNA synthesis
Featured Products
Pseudo-UTP, also known as pseudouridine-5’-O-triphosphate, is one of the most commonly used modified nucleoside-5’-O-triphosphates. Pseudo-UTP is a building block for the polymerase-mediated synthesis of RNA molecules. RNA molecules, especially messenger RNAs (mRNAs), have widespread applications in therapeutic and diagnostic areas, and have demonstrated their superiority over plasmid DNA techniques in both gene and vaccination therapy. Compared with uridine-containing unmodified mRNAs, the application of pseudouridine-containing modified mRNAs exhibits better nuclease stability, immunogenicity, and translational properties. Thus, pseudo-UTP could be used to develop drugable mRNAs with improved properties, by replacing the standard bases by modified ones.
Reference:
1. Shanmugasundaram M, Senthilvelan A, Kore AR. Gram-scale chemical synthesis of base-modified ribonucleoside-5'-O-triphosphates. Current Protocols in Nucleic Acid Chemistry, 2016, 67: 13.15.1-13.15.10.
- 1. Xiaoqing Guan, Abhishek K Verma, et al. "A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV." Vaccines (Basel). 2024 Jun 1;12(6):605. PMID: 38932334
- 2. Jintao Li, et al. "Enhancement of SARS-CoV-2 mRNA Vaccine Efficacy through the Application of TMSB10 UTR for Superior Antigen Presentation and Immune Activation." Vaccines (Basel). 2024 Apr 17;12(4):432. PMID: 38675814
- 3. Jing Lu, Shudan Tan, et al. "Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies." Emerg Microbes Infect. 2024 Dec;13(1):2321994 PMID: 38377136
- 4. Peiying Li, et al. "Targeted mRNA Nanoparticles Ameliorate Blood–Brain Barrier Disruption Postischemic Stroke by Modulating Microglia Polarization." ACS Nano. 2024 Jan 30;18(4):3260-3275. PMID: 38227975
- 5. Xingdi Cheng, Sujia Liu, et al. "A Synergistic Lipid Nanoparticle Encapsulating mRNA Shingles Vaccine Induces Potent Immune Responses and Protects Guinea Pigs from Viral Challenges." Adv Mater. 2024 Mar;36(13):e2310886 PMID: 38145557
- 6. Mingzhu Gao, Maoping Tang, et al. "Modulating Plaque Inflammation via Targeted mRNA Nanoparticles for the Treatment of Atherosclerosis." ACS Nano. 2023 Sep 26;17(18):17721-17739. PMID: 37669404
- 7. Fengqiao Li, Xue-Qing Zhang, et al. "mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy." Nat Commun. 2023 Jul 15;14(1):4223. PMID: 37454146
- 8. Wanbo Tai, Jian Zheng, et al. "MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection." Virus Res. 2023 Sep:334:199156. PMID: 37336390
- 9. Gang Wang, Juan Shi, et al. "mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concern." iScience. 2022 Dec 22;25(12):105690. PMID: 36471872
- 10. Shudan Tan, Xue Hu, et al. "Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants." biorxiv.
- 11. Kyusik Q Kim, Bhagyashri D Burgute, et al. "N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products." Cell Rep. 2022 Aug 30;40(9):111300. PMID: 35988540
- 12. Yao Li, Xiaotu Ma, et al. "Rapid Surface Display of mRNA Antigens by BacteriaDerived Outer Membrane Vesicles for a Personalized Tumor Vaccine." Adv Mater. 2022 May;34(20):e2109984. PMID: 35315546
- 13. Jingjing Zhang, Yun Li, et al. "Genome-wide CRISPR/Cas9 library screen identifes PCMT1 as a critical driver of ovarian cancer metastasis." J Exp Clin Cancer Res. 2022 Jan 15;41(1):24. PMID: 35033172
- 14. Trine I Jensen, Nanna S Mikkelsen, et al. "Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi." Genome Res. 2021 Nov;31(11):2120-2130. PMID: 34407984
- 15. Cecilia Martinez Campos, Kevin Tsai, et al. "Mapping of pseudouridine residues on cellular and viral transcripts using a novel antibody-based technique." RNA. 2021 Nov;27(11):1400-1411. PMID: 34376564
- 16. Wei Wang, Shuo Feng, et al. "Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm." Acta Pharm Sin B.
- 17. Jing Lu, Guoliang Lu, et al. "A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice." Cell Res. 2020;1-4. PMID: 32801356
| Physical Appearance | Solution |
| Storage | Store at -20°C or below |
| M.Wt | 484.1 (free acid) |
| Formula | C9H15N2O15P3 (free acid) |
| Synonyms | Pseudouridine-5'-Triphosphate, 5-Ribosyl Uracil |
| Chemical Name | lithium (5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl triphosphate |
| SDF | Download SDF |
| Canonical SMILES | O=C(NC=C1C2C(O)C(O)C(COP([O-])(OP([O-])(OP([O-])([O-])=O)=O)=O)O2)NC1=O.[Li+].[Li+].[Li+].[Li+] |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
-
Purity = 98.73% by AX-HPLC
- COA (Certificate Of Analysis)
- HPLC
- MS (Mass Spectrometry)
- MSDS (Material Safety Data Sheet)
Chemical structure
Related Biological Data
